✦ LIBER ✦

Effects of xamoterol a new beta-adrenoceptor partial agonist, in patients with angina pectoris

✍ Scribed by L. Barrios; J. Geboers; J. H. Piessens; H. Geest

Publisher: Springer
Year: 1986
Tongue: English
Weight: 405 KB
Volume: 29
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00615956

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differential effects of β-adrenoceptor p

Differential effects of β-adrenoceptor partial agonists in patients with postural hypotension

✍ J. Mehlsen; C. Stadeager; J. Trap-Jensen 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 470 KB

The central haemodynamic effects of pindolol and xamoterol have been investigated in patients with postural hypotension. Pindolol is a non-selective beta-adrenoceptor partial agonist, whereas xamoterol is beta 1-selective and possesses a higher degree of agonist activity. The study comprised 16 pati

Therapeutic efficacy of a new transderma

Therapeutic efficacy of a new transdermal system containing nitroglycerin in patients with angina pectoris

✍ A. J. Georgopoulos; A. Markis; H. Georgiadis 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 452 KB

Effects of prenalterol, a partial beta a

Effects of prenalterol, a partial beta adrenoceptor agonist, on the left ventricular function in anesthetized cardiac denervated beagle dogs

✍ Lars Ek; Jan-Arne Bjökman; Bhagavan S. Jandhyala 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB 👁 1 views

Metabolic and haemodynamic effects and p

Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, in man

✍ O. Rönn; E. Fellenius; C. Graffner; G. Johnsson; P. Lundborg; L. Svensson 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 619 KB

Haemodynamic effects and pharmacokinetic

Haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, and its interaction with metoprolol in man

✍ O. Rönn; Christina Graffner; G. Johnsson; L. Jordö; P. Lundborg; J. Wikstrand 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 525 KB

Low-dose verapamil in middle-aged and el

Low-dose verapamil in middle-aged and elderly patients with angina pectoris: No evidence of increased susceptibility to the cardiac effects

✍ Jawad H. Ahmed; Henry L. Elliott; Peter A. Meredith; John L. Reid 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 482 KB

This study investigated the cardiac responses and pharmacokinetics following the acute and chronic administration of verapamil in 14 middle-aged and elderly patients with ischemic heart disease (age range 42-76 years). There were small significant reductions in heart rate during chronic treatment, b